Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
29.33
+1.46 (5.24%)
At close: May 12, 2025, 4:00 PM
28.00
-1.33 (-4.53%)
After-hours: May 12, 2025, 6:20 PM EDT
Avidity Biosciences Market Cap
Avidity Biosciences has a market cap or net worth of $3.54 billion as of May 12, 2025. Its market cap has increased by 47.54% in one year.
Market Cap
3.54B
Enterprise Value
2.16B
1-Year Change
47.54%
Ranking
Category
Stock Price
$29.33
Market Cap Chart
Since June 12, 2020, Avidity Biosciences's market cap has increased from $1.01B to $3.54B, an increase of 250.91%. That is a compound annual growth rate of 29.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 3.36B | -3.17% |
| Dec 31, 2024 | 3.47B | 417.36% |
| Dec 29, 2023 | 670.62M | -54.52% |
| Dec 30, 2022 | 1.47B | 32.27% |
| Dec 31, 2021 | 1.11B | 16.40% |
| Dec 31, 2020 | 957.68M | -4.94% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |